BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $643,978 (99.2% shares, 0.8% debt)

Holdings (34)

— BLUEPRINT MEDICINES CORP 12.5%

Value ($000) $80,649 Shares 1,591,646 Est. Cost $25.16 Unrealized —

— CHEMOCENTRYX INC 12.0%

Value ($000) $77,205 Shares 8,248,416 Est. Cost $8.94 Unrealized —

— ARRAY BIOPHARMA INC 7.9%

Value ($000) $50,719 Shares 6,059,625 Est. Cost $6.51 Unrealized —

ANAB ANAPTYSBIO INC 6.2%

Value ($000) $39,705 Shares 1,659,200 Est. Cost $23.32 Unrealized +7.8%

— LOXO ONCOLOGY INC 5.8%

Value ($000) $37,159 Shares 463,386 Est. Cost $53.87 Unrealized —

— GLYCOMIMETICS INC 5.1%

Value ($000) $33,147 Shares 2,970,182 Est. Cost $7.30 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 4.9%

Value ($000) $31,418 Shares 2,026,998 Est. Cost $14.10 Unrealized +6.9%

— CTI BIOPHARMA CORP 4.4%

Value ($000) $28,454 Shares 8,596,357 Est. Cost $3.77 Unrealized —

— FORWARD PHARMA A/S 4.4%

Value ($000) $28,215 Shares 1,387,853 Est. Cost $20.85 Unrealized —

— CONCERT PHARMACEUTICALS INC 4.0%

Value ($000) $25,904 Shares 1,856,895 Est. Cost $13.78 Unrealized —

CYTK CYTOKINETICS INC 3.7%

Value ($000) $24,083 Shares 1,990,321 Est. Cost $7.03 Unrealized +97.7%

— PIERIS PHARMACEUTICALS INC 2.7%

Value ($000) $17,669 Shares 3,491,933 Est. Cost $3.18 Unrealized —

— ACHILLION PHARMACEUTICALS INC 2.5%

Value ($000) $16,019 Shares 3,490,077 Est. Cost $4.18 Unrealized —

— TOCAGEN INC 2.4%

Value ($000) $15,387 Shares 1,279,078 Est. Cost $12.03 Unrealized —

— BIOLINERX LTD 2.3%

Value ($000) $14,875 Shares 17,500,000 Est. Cost $0.96 Unrealized —

— ONCOMED PHARMACEUTICALS INC 2.3%

Value ($000) $14,653 Shares 4,400,289 Est. Cost $8.77 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 1.9%

Value ($000) $12,350 Shares 7,866,108 Est. Cost $3.51 Unrealized -45.1%

— CASCADIAN THERAPEUTICS INC 1.8%

Value ($000) $11,640 Shares 3,133,224 Est. Cost $4.31 Unrealized —

XENE XENON PHARMACEUTICALS INC 1.7%

Value ($000) $11,084 Shares 3,518,830 Est. Cost $8.45 Unrealized -53.8%

XOMA XOMA CORP DEL 1.6%

Value ($000) $10,505 Shares 1,502,800 Est. Cost $5.35 Unrealized +24.3%

— ARQULE INC 1.4%

Value ($000) $9,176 Shares 7,400,128 Est. Cost $1.87 Unrealized —

— SPRING BK PHARMACEUTICALS INC 1.3%

Value ($000) $8,332 Shares 615,384 Est. Cost $13.54 Unrealized —

— IGNYTA INC 1.1%

Value ($000) $7,245 Shares 700,000 Est. Cost $10.35 Unrealized —

— NIVALIS THERAPEUTICS INC 1.0%

Value ($000) $6,374 Shares 2,644,806 Est. Cost $5.02 Unrealized —

— GTX INC DEL 0.9%

Value ($000) $5,864 Shares 1,108,433 Est. Cost $5.28 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.8%

Value ($000) $5,025 Shares 10,000,000 Est. Cost $0.27 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.7%

Value ($000) $4,781 Shares 1,770,692 Est. Cost $3.85 Unrealized —

— ADURO BIOTECH INC 0.5%

Value ($000) $3,420 Shares 300,000 Est. Cost $11.40 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 0.5%

Value ($000) $3,318 Shares 274,196 Est. Cost $10.68 Unrealized 0.0%

— REGULUS THERAPEUTICS INC 0.5%

Value ($000) $3,232 Shares 3,278,900 Est. Cost $1.11 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.3%

Value ($000) $2,131 Shares 734,976 Est. Cost $3.32 Unrealized —

ANTH ANTHERA PHARMACEUTICALS INC 0.3%

Value ($000) $1,631 Shares 1,006,507 Est. Cost $2.24 Unrealized 0.0%

— PAIN THERAPEUTICS INC 0.2%

Value ($000) $1,341 Shares 325,508 Est. Cost $4.12 Unrealized —

FATE FATE THERAPEUTICS INC 0.2%

Value ($000) $1,268 Shares 391,386 Est. Cost $2.68 Unrealized +43.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	1,591,646	$80,649	12.5%	$25.16	—	COM	09627Y109
—	CHEMOCENTRYX INC	8,248,416	$77,205	12.0%	$8.94	—	COM	16383L106
—	ARRAY BIOPHARMA INC	6,059,625	$50,719	7.9%	$6.51	—	COM	04269X105
ANAB	ANAPTYSBIO INC	1,659,200	$39,705	6.2%	$23.32	+7.8%	COM	032724106
—	LOXO ONCOLOGY INC	463,386	$37,159	5.8%	$53.87	—	COM	548862101
—	GLYCOMIMETICS INC	2,970,182	$33,147	5.1%	$7.30	—	COM	38000Q102
CTMX	CYTOMX THERAPEUTICS INC	2,026,998	$31,418	4.9%	$14.10	+6.9%	COM	23284F105
—	CTI BIOPHARMA CORP	8,596,357	$28,454	4.4%	$3.77	—	COM NEW	12648L601
—	FORWARD PHARMA A/S	1,387,853	$28,215	4.4%	$20.85	—	SPONSORED ADR	34986J105
—	CONCERT PHARMACEUTICALS INC	1,856,895	$25,904	4.0%	$13.78	—	COM	206022105
CYTK	CYTOKINETICS INC	1,990,321	$24,083	3.7%	$7.03	+97.7%	COM NEW	23282W605
—	PIERIS PHARMACEUTICALS INC	3,491,933	$17,669	2.7%	$3.18	—	COM	720795103
—	ACHILLION PHARMACEUTICALS INC	3,490,077	$16,019	2.5%	$4.18	—	COM	00448Q201
—	TOCAGEN INC	1,279,078	$15,387	2.4%	$12.03	—	COM	888846102
—	BIOLINERX LTD	17,500,000	$14,875	2.3%	$0.96	—	SPONSORED ADR	09071M106
—	ONCOMED PHARMACEUTICALS INC	4,400,289	$14,653	2.3%	$8.77	—	COM	68234X102
INFIQ	INFINITY PHARMACEUTICALS INC	7,866,108	$12,350	1.9%	$3.51	-45.1%	COM	45665G303
—	CASCADIAN THERAPEUTICS INC	3,133,224	$11,640	1.8%	$4.31	—	COM NEW	14740B606
XENE	XENON PHARMACEUTICALS INC	3,518,830	$11,084	1.7%	$8.45	-53.8%	COM	98420N105
XOMA	XOMA CORP DEL	1,502,800	$10,505	1.6%	$5.35	+24.3%	COM NEW	98419J206
—	ARQULE INC	7,400,128	$9,176	1.4%	$1.87	—	COM	04269E107
—	SPRING BK PHARMACEUTICALS INC	615,384	$8,332	1.3%	$13.54	—	COM	849431101
—	IGNYTA INC	700,000	$7,245	1.1%	$10.35	—	COM	451731103
—	NIVALIS THERAPEUTICS INC	2,644,806	$6,374	1.0%	$5.02	—	COM	65481J109
—	GTX INC DEL	1,108,433	$5,864	0.9%	$5.28	—	COM NEW	40052B207
—	OREXIGEN THERAPEUTICS INC	10,000,000	$5,025	0.8%	$0.27	—	NOTE 2.750%	686164AB0
—	SUNESIS PHARMACEUTICALS INC	1,770,692	$4,781	0.7%	$3.85	—	COM PAR	867328700
—	ADURO BIOTECH INC	300,000	$3,420	0.5%	$11.40	—	COM	00739L101
CRVS	CORVUS PHARMACEUTICALS INC	274,196	$3,318	0.5%	$10.68	0.0%	COM	221015100
—	REGULUS THERAPEUTICS INC	3,278,900	$3,232	0.5%	$1.11	—	COM	75915K101
—	OREXIGEN THERAPEUTICS INC	734,976	$2,131	0.3%	$3.32	—	COM NEW	686164302
ANTH	ANTHERA PHARMACEUTICALS INC	1,006,507	$1,631	0.3%	$2.24	0.0%	COM	03674U300
—	PAIN THERAPEUTICS INC	325,508	$1,341	0.2%	$4.12	—	COM NEW	69562K506
FATE	FATE THERAPEUTICS INC	391,386	$1,268	0.2%	$2.68	+43.1%	COM	31189P102